MedTrace Logo

Neural Stem Cell Transplantation in Traumatic Spinal Cord Injury

NCT02326662 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2015-10-27

No results posted yet for this study

Summary

This research investigates the use of autologous neural stem cells in patients with complete traumatic spinal cord injury.

Conditions

  • Spinal Cord Injury

Interventions

BIOLOGICAL

Autologous Stem Cell Transplantation

Autologous neural stem cell transplantation Stem Cell Transplantation by intraspinal and intrathecal injection with 3D matrix as needed

Sponsors & Collaborators

  • Novagenesis Foundation

    collaborator UNKNOWN

  • Ophiuchus Technologies AG

    collaborator UNKNOWN

  • Federal Research Clinical Center of Federal Medical & Biological Agency, Russia

    lead OTHER_GOV

Principal Investigators

  • Alexander Averyanov, MD · Federal Research Clinical Center FMBA of Russia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-10-31
Completion
2018-12-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02326662 on ClinicalTrials.gov